Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma

J. A. Sparano, R. I. Fisher, M. Sunderland, K. Margolin, M. L. Ernest, M. Sznol, M. B. Atkins, J. P. Dutcher, K. C. Micetich, G. R. Weiss, J. H. Doroshow, F. R. Aronson, L. V. Rubinstein, J. W. Mier

Research output: Contribution to journalArticlepeer-review

167 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences